• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AMCP 2011: Interview with Dr. Jonathan Meyer of the University of California at San Diego

Article

Dr. Jonathan Meyer discusses the importance of prescribing the most appropriate medications for schizophrenia patients.

Dr. Jonathan Meyer, Assistant Clinical Professor of Psychiatry at the University of California at San Diego, speaks about the importance of prescribing the most targeted, cost-effective, and appropriate medications for schizophrenia patients.

Related Videos
Roy Mathew, MD, screenshot
Dr Marco del Riccio
Peter Voorhees, MD, Atrium Health Levine Cancer Institute
Dr David Kuter
Dr Amrita Basu
Danielle Roman, PharmD, BCOP, Allgheny Health Network
Dr Eric Yang
Dr Adam Brufsky
Eleanor Perfetto, PhD
Related Content
DIverse kids getting vaccinated - prostock-studio - stock.adobe.com.jpeg

CDC Reduces US Childhood Immunization Schedule From 17 to 11 Diseases

January 5th 2026
Article

The CDC announced a significant change to the childhood immunization schedule that would reduce vaccine recommendations.

Read More

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

January 1st 2026
Podcast

Sachin H. Jain, MD, MBA, discusses 2026 health care predictions, including AI adoption, GLP-1 demand, MAHA growth, DEI’s return, and policy shifts.

Listen

Explore AJMC’s top 5 obesity insights of 2025, covering GLP-1 therapy trends, access, costs, and strategies to improve patient care.

Top 5 Most-Read Obesity Content of 2025

December 30th 2025
Article

Our top 5 obesity articles of 2025 highlight GLP-1 prescribing trends, insurance coverage, co-pay caps, real-world use, and access challenges.

Read More

managed care cast logo

Switching From MA to TM Increases Mental Health Care Use: Angela Liu, PhD, MPH

December 23rd 2025
Podcast

Angela Liu, PhD, MPH, speaks about her study that examined mental health care use by Medicare beneficiaries before and after switching from MA to TM.

Listen

The Top 5 Gated Content of 2025

Top 5 Gated Content for 2025

December 29th 2025
Article

Explore the evolving landscape of drug pricing, reproductive rights, and health policy in 2025, featuring insights on SC pembrolizumab and RFK Jr's hearings.

Read More

The top 5 reimbursement content of 2025

Top 5 Most-Read Reimbursement Content of 2025

December 28th 2025
Article

The most-viewed content focused on the “One Big Beautiful Bill,” the Most Favored Nation drug policy, and other changes under the Trump administration.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.